Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cassava Sciences, Inc. - Common Stock
(NQ:
SAVA
)
2.150
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cassava Sciences, Inc. - Common Stock
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
2 High-Risk, High-Reward Stocks That Could Go to the Moon
↗
July 22, 2021
Risk-averse investors may want to look elsewhere.
Via
The Motley Fool
61 Biggest Movers From Yesterday
↗
July 22, 2021
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares surged 159.2% to close at $5.34 on Wednesday after the company received a $28.3 million purchase order from Brazil's...
Via
Benzinga
Why Cassava Sciences Stock Soared Today
↗
June 21, 2021
Investors applauded the company's update on its clinical programs.
Via
The Motley Fool
Here's Why Cassava Sciences Is Surging Today
↗
July 21, 2021
Investors are excited about upcoming presentations scheduled for the annual Alzheimer's Association International Conference.
Via
The Motley Fool
SAVA Stock: Two Dates Cassava Investors Need to Mark on Their Calendars
↗
July 21, 2021
SAVA stock is flying upward today as investors clamor to hear information around two new products. Investors should save two upcoming dates.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
July 21, 2021
Gainers Chembio Diagnostics (NASDAQ:CEMI) stock rose 189.72% to $5.97 during Wednesday's regular session. Trading volume for Chembio Diagnostics's stock is 265.3...
Via
Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
↗
July 21, 2021
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase order from Brazil's Bio-Manguinhos to...
Via
Benzinga
Building A Bear-Proof Portfolio: Investing Safely Up As The Fear & Greed Index Approaches Early 2020 Levels.
↗
July 20, 2021
Market Fear Gauge Approaches 2020 Levels As ZeroHedge reported on Monday, the Fear & Greed gauge has approached early 2020 levels. Screen capture via...
Via
Benzinga
Here's Why Cassava Sciences Is Up 1,152% in the First Half of 2021
↗
July 20, 2021
This small-cap biotech has shot up in value as the company's Alzheimer's drug makes it way through clinical trials.
Via
The Motley Fool
Is Now The Time To Buy Stock In Cassava Sciences, Facebook Or Apple?
↗
July 20, 2021
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why I...
Via
Benzinga
Why Is Cassava Sciences Stock Soaring in 2021?
↗
July 20, 2021
The stock market is excited by the clinical trial results for its Alzheimer's drug.
Via
The Motley Fool
10 Biggest Price Target Changes For Tuesday
↗
July 20, 2021
Citigroup boosted International Business Machines Corporation (NYSE:
Via
Benzinga
Building A Bear-Proof Portfolio
↗
July 20, 2021
How to invest confidently as the Fear & Greed gauge hits early 2020 fear levels.
Via
Talk Markets
Understanding Cassava Sciences's Unusual Options Activity
↗
July 16, 2021
Cassava Sciences (NASDAQ:SAVA) shares experienced unusual options activity on Friday. The stock price moved down to $79.73 following the option alert. Sentiment: BEARISH Option...
Via
Benzinga
54 Biggest Movers From Yesterday
↗
July 16, 2021
Gainers Sight Sciences, Inc. (NASDAQ: SGHT) shares jumped 39.6% to settle at $33.50 on Thursday as the company priced its IPO at $24 per share. Cinedigm Corp. (NASDAQ: CIDM)...
Via
Benzinga
Topics
Initial Public Offering
Why Cassava Sciences Stock Moved Higher Monday
↗
July 12, 2021
The biotech stock bounced back big Monday after tumbling on Friday.
Via
The Motley Fool
38 Stocks Moving In Monday's Mid-Day Session
↗
July 12, 2021
Gainers State Auto Financial Corporation (NASDAQ: STFC) shares jumped 189.5% to $49.96 after the company agreed to be acquired by Liberty Mutual Insurance for $52 per share in...
Via
Benzinga
24 Stocks Moving in Monday's Pre-Market Session
↗
July 12, 2021
Gainers SGOCO Group, Ltd. (NASDAQ: SGOC) shares rose 67.7% to $16.42 in pre-market trading after jumping around 280% on Friday. MER Telemanagement Solutions Ltd. (NASDAQ: MTSL)...
Via
Benzinga
64 Biggest Movers From Friday
↗
July 12, 2021
Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares surged 597.8% to settle at $34.89 on Friday as the company priced its IPO at $5 per share. SGOCO Group, Ltd. (NASDAQ: SGOC)...
Via
Benzinga
Topics
Initial Public Offering
Biogen Stock Drags On Alzheimer's Players As FDA Requests Review Of Aduhelm Approval
↗
July 09, 2021
Biogen stock tumbled Friday after the FDA requested an independent review of the process that led to its recent Alzheimer's approval.
Via
Investor's Business Daily
Follow the Money to Find Out What's Working This Year
↗
July 06, 2021
The notorious dip-buyers have been aggressively supporting this market ever since the pandemic low point last year. If they become fully invested, the flow of new money into the market could stop.
Via
Talk Markets
Neurodegenerative Disease And Cancer Stocks Among Top Biotech Gainers In 2021
↗
July 04, 2021
Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF IBB advancing about 8% year-to-date compared to the roughly 14% gain for the S&P...
Via
Talk Markets
Topics
Stocks
Neurodegenerative Disease, Cancer Stocks Among Top Biotech Gainers In 2021
↗
July 04, 2021
Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) advancing about 8% year-to-date ...
Via
Benzinga
This Biotech Stock Is Beating GameStop
↗
July 01, 2021
Now the question is whether the gains are here to stay.
Via
The Motley Fool
Is It Too Late to Buy Cassava Sciences Stock?
↗
June 26, 2021
Just because the stock has had a massive run doesn't mean its biggest gains are behind it.
Via
The Motley Fool
PreMarket Prep Recap: The 4 Stocks Dennis Dick Bought Yesterday
↗
June 24, 2021
On Wednesday’s PreMarket Prep, co-hosts Joel Elconin and Dennis Dick discussed the bullish chart setups in several tech stocks. ...
Via
Benzinga
Could Cassava Sciences Be a Millionaire-Maker Stock?
↗
June 24, 2021
Can this biotech underdog develop an Alzheimer's drug investors can count on?
Via
The Motley Fool
44 Biggest Movers From Yesterday
↗
June 23, 2021
Gainers Alfi, Inc. (NASDAQ: ALF) shares jumped 108.9% to settle at $16.29 on Tuesday following exclusive Benzinga reporting the company will buyback up to $2 million of its...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
June 22, 2021
Gainers Anavex Life Sciences (NASDAQ:AVXL) stock increased by 17.07% to $25.92 during Tuesday's regular session. As of 12:33 EST, this security is trading at a volume...
Via
Benzinga
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
↗
June 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...
Via
Benzinga
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today